Enhancement of pulmonary clearance of Moraxella (Branhamella) catarrhalis following immunization with outer membrane protein CD in a mouse model

Journal of Infectious Diseases

Volumn 178, Issue 6, 1998, Pages 1667-1675

  Murphy, Timothy F ^a   Kyd, Jennelle M ^b   John, Anna ^b   Kirkham, Charmaine ^b   Cripps, Allan W ^b  

^a VA WESTERN NEW YORK HEALTHCARE SYSTEM   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL VACCINE; OUTER MEMBRANE PROTEIN;

ACTIVE IMMUNIZATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL PNEUMONIA; HOST RESISTANCE; INFECTION RESISTANCE; LUNG CLEARANCE; MORAXELLA CATARRHALIS; MOUSE; NONHUMAN; OUTER MEMBRANE; PRIORITY JOURNAL; STRAIN DIFFERENCE;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODY FORMATION; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL VACCINES; BLOOD BACTERICIDAL ACTIVITY; BRONCHOALVEOLAR LAVAGE FLUID; CLONING, MOLECULAR; HUMANS; IMMUNIZATION; IMMUNIZATION SCHEDULE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INTESTINAL MUCOSA; LUNG; MALE; MICE; MICE, INBRED BALB C; MORAXELLA (BRANHAMELLA) CATARRHALIS; NEISSERIACEAE INFECTIONS; PEYER'S PATCHES; RECOMBINANT PROTEINS;

EID: 0031736510     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314501     Document Type: Article

References (22)

1. Murphy TF. Branhamella catarrhalis: epidemiology, surface antigenic structure, and immune response. Microbiol Rev 1996;60:267-79.
2. Murphy TF. Branhamella catarrhalis: epidemiological and clinical aspects of a human respiratory tract pathogen. Thorax 1998;53:124-8.
3. Klein JO. Otitis media. Clin Infect Dis 1994;19:823-33.
4. Pukander JS, Jero JP, Kaprio EA, Sorri MJ. Clarithromycin vs. amoxicillin suspensions in the treatment of pediatric patients with acute otitis media. Pediatr Infect Dis J 1993;12(suppl):S118-21.
5. Ruuskanen O, Heikkinen T. Otitis media: etiology and diagnosis. Pediatr Infect Dis J 1994;13(suppl):S23-6.
6. Aspin MM, Hoberman A, McCarty J, et al. Comparative study of the safety and efficacy of clarithromycin and amoxicillin-clavulanate in the treatment of acute otitis media in children. J Pediatr 1994;125:135-41.
7. Gehanno P, Berche P, Boucot I, et al. Comparative efficacy and safety of cefprozil and amoxycillin-clavulanate in the treatment of acute otitis media in children. J Antimicrob Chemother 1994;33:1209-18.
8. Murphy TF, Sethi S. Bacterial infection in chronic obstructive pulmonary disease. Am Rev Respir Dis 1992;146:1067-83.
9. Hager H, Verghese A, Alvarez S, Berk SL. Branhamella catarrhalis respiratory infections. Rev Infect Dis 1987;9:1140-9.
10. Barreiro B, Esteban L, Prats E, Verdaguer E, Dorca J, Manresa F. Branhamella catarrhalis respiratory infections. Eur Respir J 1992;5:675-9.
11. Boyle FM, Georghiou PR, Tilse MH, McCormack JG. Branhamella (Moraxella) catarrhalis: pathogenic significance in respiratory infections. Med J Aust 1991;154:592-6.
12. Verghese A, Roberson D, Kalbfleisch JH, Sarubbi F. Randomized comparative study of cefixime versus cephalexin in acute bacterial exacerbations of chronic bronchitis. Antimicrob Agents Chemother 1990;34:1041-4.
13. Dickinson DP, Loos BG, Dryja DM, Bernstein JM. Restriction fragment mapping of Branhamella catarrhalis: a new tool for studying the epidemiology of this middle ear pathogen. J Infect Dis 1988;158:205-8.
14. Picard B, Goullet P, Denamur E, Suerdmondt G. Esterase electrophoresis: a molecular tool for studying the epidemiology of Branhamella catarrhalis nosocomial infection. Epidemiol Infect 1989;103:547-54.
15. Kawakami Y, Ueno I, Katsuyama T, Furihata K, Matsumoto H. Restriction fragment length polymorphism (RFLP) of genomic DNA of Moraxella (Branhamella) catarrhalis isolates in a hospital. Microbiol Immunol 1994;38:891-5.
16. Patterson JE, Patterson TF, Farrel P, Hierholzer WJ Jr, Zervos MJ. Evaluation of restriction endonuclease analysis as an epidemiologic typing system for Branhamella catarrhalis. J Clin Microbiol 1989;27:944-6.
17. Morgan MG, McKenzie H, Enright MC, Bain M, Emmanuel FXS. Use of molecular methods to characterize Moraxella catarrhalis strains in a suspected outbreak of nosocomial infection. Eur J Clin Microbiol Infect Dis 1992;11:305-12.
18. McKenzie H, Morgan MG, Jordens JZ, Enright MC, Bain M. Characterisation of hospital isolates of Moraxella (Branhamella) catarrhalis by SDS-PAGE of whole-cell proteins, immunoblotting and restriction-endonuclease analysis. J Med Microbiol 1992;37:70-6.
19. Patterson TF, Patterson JE, Masecar BL, Barden GE, Hierholzer WJ Jr, Zervos MJ. A nosocomial outbreak of Branhamella catarrhalis confirmed by restriction endonuclease analysis. J Infect Dis 1988;157:996-1001.
20. Cook PP, Hecht DW, Snydman DR. Nosocomial Branhamella catarrhalis in a paediatric intensive care unit: risk factors for disease. J Hosp Infect 1989;13:299-307.
21. Richards SJ, Greening AP, Enright MC, Morgan MG, McKenzie H. Outbreak of Moraxella catarrhalis in a respiratory unit. Thorax 1993;48:91-2.
22. Sarwar J, Campagnari AA, Kirkham C, Murphy TF. Characterization of an antigenically conserved heat-modifiable major outer membrane protein of Branhamella catarrhalis. Infect Immun 1992;60:804-9.